Uterine and ovarian changes during testosterone administration in young female-to-male transsexuals

Female-to-male transition remains a specific clinical indication for long-term testosterone administration. There is a limited number of studies dealing with the effect of androgen treatment on their female receptive targets (mainly breast and uterus) and the knowledge in this field is scarce and, sometimes, contradictory.We performed a prospective study including 12 patients aged between 20 years and 32 years, with a diagnosis of gender...